Chrysidis, Stavros Lage-Hansen, Philip Rask Svendsen, Nikoletta Diamantopoulos, Andreas P.
Published in
BMC Rheumatology
Objectives This study aimed to investigate the hospitalisation rates and the reasons for hospitalisation in patients with polymyalgia rheumatica (PMR). Furthermore, it aimed to clarify the impact of a newly established Fast Track Clinic (FTC) approach on hospitalisation rates in connection with PMR diagnosis. Methods Patients diagnosed with PMR at ...
Bashiri, Hamidreza Karimi, Nooshin Mostafaei, Shayan Baghdadi, Azarakhsh Nejadhosseinian, Mohammad Faezi, Seyedeh Tahereh
Published in
BMC Rheumatology
Background Ocular manifestations are common in systemic lupus erythematosus (SLE). Retinopathy has previously been linked to disease severity and might have a significant impact on the patient’s quality of life and has also been associated with a poor prognosis in SLE. This study aimed to determine the prevalence of retinopathy among patients who a...
Brow, Jeffrey D. Zhu, Daisy Drevlow, Barbara E.
Published in
BMC Rheumatology
Background Scleroderma and adult onset Still’s disease (AOSD) are both uncommon autoimmune disorders. These two disorders have rarely been documented to occur simultaneously. In fact, after a thorough literature review, we discovered only one prior case report in a pregnant individual. Here, we describe the first documented case of scleroderma and ...
Deodhar, Atul Mease, Philip Marzo-Ortega, Helena Hunter, Theresa Sandoval, David Kronbergs, Andris Lauzon, Steven Leung, Ann Navarro-Compán, Victoria
Published in
BMC Rheumatology
Background Patients with non-radiographic axial spondyloarthritis experience negative impacts on sleep, work productivity, and activity impairment. Ixekizumab, a monoclonal antibody selectively targeting interleukin-17A, has shown efficacy in treating the signs and symptoms of non-radiographic axial spondyloarthritis. This analysis evaluated the ef...
Deodhar, Atul A. Mease, Philip J. Rahman, Proton Navarro-Compán, Victoria Strand, Vibeke Hunter, Theresa Bolce, Rebecca Leon, Luis Lauzon, Steve Marzo-Ortega, Helena
...
Published in
BMC Rheumatology
Background This analysis assessed improvements in patients with radiographic axial spondyloarthritis (r-axSpA) treated with ixekizumab in the Assessment of Spondyloarthritis International Society (ASAS) treatment response domains and additional patient-reported outcomes at 1 year of treatment. Methods COAST-V and COAST-W were 52-week, phase 3, rand...
Shaffer, Andrew Rahn, Elizabeth Saag, Kenneth Mudano, Amy Gaffo, Angelo
Published in
BMC Rheumatology
Background Previous studies have noted significant variation in serum urate (sUA) levels, and it is unknown how this influences the accuracy of hyperuricemia classification based on single data points. Despite this known variability, hyperuricemic patients are often used as a control group in gout studies. Our objective was to determine the accurac...
Sada, Ken-ei Miyauchi, Atsushi Hashimoto, Daisuke Ino, Riku Nojima, Shigeru Yamanaka, Shingo Kawamura, Masafumi
Published in
BMC Rheumatology
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is an anti-neutrophil antibody (ANCA)-associated necrotizing vasculitis, which predominantly affects small to medium vessels, and is associated with asthma and eosinophilia. EGPA has two different pathogenic aspects: eosinophilic granulomatous inflammation and ANCA-associated inflammat...
Phang, Jie Kie Khor, Andrew Yu Keat Kwan, Yu Heng Ng, Chin Teck Fong, Warren
Published in
BMC Rheumatology
Background Patients with axial spondyloarthritis (axSpA) may experience spinal stiffness and pain, leading to reduced physical function and quality of life. Despite the benefits of physical activity (PA) and exercise, previous studies have demonstrated lower levels of PA among patients with axSpA. This study aims to examine the patterns of PA among...
Kim, Se Hee Lee, Sang-Heon Kim, Hae-Rim Min, Hong Ki
Published in
BMC Rheumatology
Background Cardiovascular diseases (CVDs) are the leading cause of death in patients with rheumatoid arthritis (RA). Coronary artery calcium (CAC) score quantifies the severity of atherosclerosis. We estimated CVD risk using several methods and compared these with the CAC score to identify the most suitable CVD risk calculator in RA patients. Metho...
Robinson, Philip C. Frampton, Christopher Phipps-Green, Amanda Neogi, Tuhina Stamp, Lisa Taylor, William Merriman, Tony R. Dalbeth, Nicola
Published in
BMC Rheumatology
Introduction Elevated serum urate (SU) concentration is the central risk factor for the development of gout. The aim of this study was to examine the incidence of gout in people with low and normal SU levels ( 7.00 mg/dL was 12.2%. In an adjusted Cox proportional hazards model, compared to the referent baseline SU 7.00 mg/dL (HR 18.62). Conclusion...
